Результаты поиска

Тенденции и различия в бремени аутоиммунных заболеваний в Китае и во всем мире: сравнительный анализ на основе исследования глобального бремени болезней 2021.

Цель этого исследования состояла в том, чтобы количественно оценить долгосрочные тенденции и бремя 5 аутоиммунные заболевания в Китае и в мире 1990 в адрес 2021 Использование глобального бремени болезней 2021 :: данные и выявление движущих факторов изменений, которыми следует руководствоваться при планировании мероприятий в области профилактики и здравоохранения. Использование глобального бремени болезней 2021 данные, мы проанализировали тип 1 сахарный диабет (T1DM), воспалительный кишечник (IBD), множественный склероз (MS), псориаз (PS) и ревматоидный артрит (RA) в Китае и во всем мире 1990 в

Early Experience with Tarlatamab (T-Cell Engagers) for Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Canada: Lessons Learned and Implementation Strategies.

As bispecific T-cell engagers (TCEs) gain traction in the oncology treatment landscape, cancer centres must develop robust clinical pathways to ensure their safe and efficient delivery. Given the limited experience of the Canadian medical oncology community with TCEs, collecting and publishing early clinical experiences with these novel agents will be essential to inform best practices and support their safe and effective adoption across the broader Canadian oncology community. The approval of tarlatamab, the first-in-class delta-like ligand 3 (DLL3)-targeted TCE for extensive-stage small cell

Risk and Outcome of Breakthrough COVID-19 Infections in Vaccinated Patients With Cancer: Real-World Evidence From the National COVID Cohort Collaborative.

PurposeTo provide real-world evidence on risks and outcomes of breakthrough COVID-19 infections in vaccinated patients with cancer using the largest national cohort of COVID-19 cases and controls.MethodsWe used the National COVID Cohort Collaborative (N3C) to identify breakthrough infections between December 1, 2020, and May 31, 2021. We included patients partially or fully vaccinated with mRNA COVID-19 vaccines with no prior SARS-CoV-2 infection record. Risks for breakthrough infection and severe outcomes were analyzed using logistic regression.ResultsA total of 6,860 breakthrough cases were

Federated Computing in Orthopaedic Surgery: A Paradigm Shift in Collaborative Multicenter Research.

➢ Multicenter studies remain rare in orthopaedics (9.9% of recent publications) due to regulatory complexity, restrictive data-sharing policies, and administrative delays, despite their proven value in generating robust, generalizable evidence. ➢ Federated computing (FC) brings analytic code to each institution's data and returns only encrypted, aggregated results. This preserves patient privacy, maintains institutional control, and streamlines compliance by reducing or eliminating the need for complex data-use agreements. ➢ Extensive applications in other medical fields show that FC can match

CAR-Based Cell and Gene Therapies: Global Clinical Landscape and Emerging Therapeutic Strategies from ClinicalTrials.gov.

Chimeric Antigen Receptor (CAR)-based cell and gene therapies have become transformative treatments, offering targeted and durable responses, especially in hematologic malignancies. This review analyzes 1,744 CAR clinical trials registered on Clinical-Trials.gov as of 2024, focusing on platform types, indications, target antigens, therapeutic strategies, and late-phase development. CAR-T therapies predominate, followed by CAR-NK, CAR-NKT, CAR-M and CAR-DC platforms. Approximately 92% of trials target tumors, with hematologic malignancies accounting for 65% of indications; CD19 and BCMA are pri

Clinical decision support in hematological malignancies using a case-grounded AI agent.

Multidisciplinary tumor boards integrate longitudinal treatment histories, molecular profiling and rapidly evolving evidence to guide decisions in hematological malignancies, yet access to this level of subspecialty deliberation is increasingly uneven. Here we develop HemaGuide, a locally deployable, modular large language model agent that converts unstructured clinical documents into structured case representations, autonomously routes cases to specialized decision modes ('guideline', 'advanced' and 'molecular') and grounds recommendations in disease-specific guideline flowcharts and a clinic

Radioligand Therapy in Cancer Management: A Global Perspective.

Radioligand therapy (RLT) is a targeted treatment modality that combines a tumour-specific ligand with a therapeutic radionuclide. Once administered, the radiopharmaceutical binds selectively to cancer-associated targets, delivering cytotoxic radiation directly to tumour cells while sparing surrounding tissues. Two RLT agents, [177Lu]Lu-DOTA-TATE (Lutathera®) and [177Lu]Lu-PSMA-617 (Pluvicto®), have received regulatory approval for the treatment of advanced gastroenteropancreatic neuroendocrine tumours and metastatic castration-resistant prostate cancer, respectively. As of July 2025, more tha

Reimbursement of licensed cell and gene therapies across the major European healthcare markets.

ObjectiveThe aim of this research is to identify the pricing, reimbursement, and market access (P&R&MA) considerations most relevant to advanced therapy medicinal products (ATMPs) in the Big5EU, and to inform their manufacturers about the key drivers for securing adoption at a commercially viable reimbursed price.MethodologyThe research was structured following three main steps: 1) Identifying the market access pathways relevant to ATMPs through secondary research; 2) Validating the secondary research findings and addressing any data gaps in primary research, by qualitative interviews with nat

Targeting large middle molecules: Clinical implications of expanded hemodialysis in hemodialysis care.

End-stage kidney disease (ESKD) presents a major clinical burden, with maintenance hemodialysis (HD) patients facing high cardiovascular mortality and impaired quality of life (QoL). Despite advances from low-flux to high-flux HD and the introduction of hemodiafiltration (HDF), clearance of large middle molecules (LMMs >25 kDa) remains inadequate. These molecules contribute to inflammation, oxidative stress, atherogenesis, and mineral-bone disorders, all of which worsen patient outcomes. Expanded hemodialysis (HDx), utilizing medium cutoff membranes, represents a novel approach that combines d

Advances and Challenges in Cervical Cancer: From Molecular Mechanisms and Global Epidemiology to Innovative Therapies and Prevention Strategies.

BackgroundIn the global scenario of public health, cervical cancer poses a major threat with high mortality rates, especially in women. New incidence cases and prevalence vary across different regions, as recently shown by GLOBOCAN data. The development of cervical cancer is primarily due to persistent infection by high-risk genotypes of human papillomavirus (HPV), which is a multifaceted process that is influenced by genetic, environmental, and lifestyle factors.PurposeThe goal of this study is to thoroughly investigate cervical cancer, including its etiology, molecular mechanisms, progressio

Совпадение в полном тексте источника
… In rural areas, these socioeconomic impediments had to work with a dearth of public health infrastructure. In addition, regional disparities were also noted by the survey. …

Burden of haematological malignancies among children, adolescents and young adults: Global and high-income region insights from the GBD 2021 study.

This study provides a comprehensive assessment of haematological malignancies among children, adolescents and young adults aged 0-24 years, using data from the Global Burden of Disease 2021 across 204 countries from 1990 to 2021. We found that global incidence and prevalence remained relatively stable, with approximately 150 000 new cases and over one million prevalent cases in 2021, while mortality and disability-adjusted life year (DALY) rates declined markedly. Leukaemia was the leading contributor to incidence, deaths, and DALYs, although decreases were observed across most subtypes. Age-

The outside medical evacuation for cancer from Madagascar.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Модель ОПТИ для метастатических опухолей костей: ориентированный на данные инструмент для хирургического планирования и прогнозирования.

ЦЕЛИ: Цель настоящего исследования заключается в оценке точности прогнозов и клинической применимости системы шаблона ОПТИ у турецких пациентов с длинными метастазами диафизовых костей, а также в сопоставлении прогнозов выживания и рекомендаций хирургического вмешательства с реальными результатами. ПАТИЕНТЫ И МЕТОДЫ: В период с апреля 2013 и июнь 2021, всего 108 (больные)52 мужского пола; 56 женщины; средний возраст: 64.5±10.6 годы; диапазон, 45 в адрес 83 ) с гистологическим подтвержденным метастатическим заболеванием костей, затрагивающим диафию длинных костей и прошедших хирургическое лечен

The role of AI in oncology: present applications and future horizons.

Artificial intelligence (AI) offers a powerful means to accelerate precision oncology by individualizing care in an era of rapidly evolving treatment paradigms. However, there is limited regulatory oversights for safe clinical implementation of AI, and concerns surrounding data bias, ownership, and privacy have hindered broad integration into healthcare practice. In this perspective, we offer a forward-looking roadmap for the dissemination of AI in oncology. We discuss the role for AI in guiding biomarker-driven patient selection for clinical trials and in facilitating both personalized drug s

The Burden of Cancer, Government Strategic Policies, and Challenges in Pakistan: A Comprehensive Review.

Cancer is a severe condition characterized by uncontrolled cell division and increasing reported mortality and diagnostic cases. In 2040, an estimated 28.4 million cancer cases are expected to happen globally. In 2020, an estimated 19.3 million new cancer cases (18.1 million excluding non-melanoma skin cancer) had been diagnosed worldwide, with around 10.0 million cancer deaths. Breast cancer cases have increased by 2.26 million, lung cancer by 2.21 million, stomach by 1.089 million, liver by 0.96 million, and colon cancer by 1.93 million. Cancer is becoming more prevalent in Pakistan, with 19

Неинфекционные заболевания на юго-западе Ирана: профиль и базовые данные из исследования < < Шахрекорд ПЕРСИАН Корт > > .

СПРАВОЧНАЯ ИНФОРМАЦИЯ: Критические межпровинциальные различия в структуре неинфекционных заболеваний (НИЗ) в Иране и трудности, связанные с определением методов профилактики для сокращения смертности от НИЗ, поставили под угрозу осуществление провинциального плана в области здравоохранения. Исследование < < Шахрекорд кохорт > > (СКС) было предназначено для устранения этих пробелов в Чахармахале и Бахтиари, провинции с высокой высотой на юго-западе Ирана, характеризующейся большим населением Бахтиари, а также этническими группами Фарса и Турка. МЕТОДЫ: Эта текущая группа, перспектив

Oral Presentation

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Estimating cancer incidence in Uganda: a feasibility study for periodic cancer surveillance research in resource limited settings.

BackgroundPopulation based cancer registries (PBCRs) are accepted as the gold standard for estimating cancer incidence in any population. However, only 15% of the world's population is covered by high quality cancer registries with coverage as low as 1.9% in settings such as Africa. This study was conducted to assess the operational feasibility of estimating cancer incidence using a retrospective "catchment population" approach in Uganda.MethodsA retrospective population study was conducted in 2018 to identify all newly diagnosed cancer cases between 2013 and 2017 in Mbarara district. Data wer

:: 8th Европейский конгресс фармацевтики: выдержки из выступлений

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Обзор терапии CAR T-Cell in Multieloma: канадская точка зрения.

Множественная миелома (ММ) — неизлечимая порча плазменных клеток. В контексте нынешнего стандарта лечения в Канаде результаты среди пациентов с рецидивистской/редактированной множественной миеломой (RRMM), особенно больных трехклассной (или более) рефрактной болезнью, остаются низкими. Иммунотерапия значительно изменила условия лечения MM. С тех пор 2021, two Продукты T-клетотерапии, предназначенные для ЦАРМ, а именно Idecabtagen vcleucel (Ide-Sel) (ABECMA) и Ciltacabtagen Autoleucel (Cilta-cel) (CARVYKTI)), которые имеются в США и Европе. Несмотря на то, что они продемонстрировали беспрецеден